Thursday, November 21, 2024
HomeBasketball NewsLouisville Basketball NewsLouisville-based Confluent Health appoints new CEO, founder Larry Benz transitions to new...

Louisville-based Confluent Health appoints new CEO, founder Larry Benz transitions to new role within company

Confluent Health Names New CEO as Founder Transitions to Executive Chairman

Confluent Health, a Louisville-based health care company, has announced a major leadership change as its founder transitions to a new role. Dr. Larry Benz, who founded the company in 2014 and served as its president and CEO, is now taking on the position of Executive Chairman of the board of directors. In his new role, Benz will focus on guiding the company’s strategic direction and driving growth in the musculoskeletal sector.

Stepping into the role of CEO is Dr. Kristi Henderson, a seasoned executive with over 25 years of experience in digital health. Henderson has previously served as CEO of Optum Everycare and has led clinical operations for Amazon Care. In a statement, Henderson expressed her excitement about the opportunity to work with Benz and the entire team at Confluent Health to build on the company’s successes and drive further growth and innovation.

In addition to her role as CEO, Henderson will continue to serve as the Board Chair for the American Telemedicine Association. She will be responsible for overseeing day-to-day outpatient and clinical operations at Confluent Health. Benz, on the other hand, will focus on leading the company’s digital innovation arm.

Confluent Health has also announced several other leadership appointments at its headquarters, including senior vice presidents for outpatient rehab companies, an executive vice president for Innovations, a chief marketing officer, a chief strategy officer, a chief operating officer for Evidence in Motion, and a chief legal and compliance officer.

The company has been experiencing significant growth, doubling the size of its headquarters with a $10 million expansion last year and recently receiving approval for a 10-year performance-based agreement that could provide up to $3.5 million in tax incentives. With plans to create 350 full-time jobs over the next decade, Confluent Health is poised for continued success in the health care industry.

Previous article
of a new breakthrough in cancer treatment.

Title: Breakthrough Cancer Treatment Shows Promising Results

In a groundbreaking development in the field of cancer treatment, researchers have announced a new therapy that has shown promising results in clinical trials. The treatment, known as targeted immunotherapy, works by harnessing the body’s immune system to specifically target and destroy cancer cells.

Unlike traditional chemotherapy, which can have debilitating side effects and often targets healthy cells as well as cancerous ones, targeted immunotherapy is designed to be more precise and less harmful to the patient. By using a combination of antibodies and immune cells, the therapy is able to identify and attack cancer cells while leaving healthy cells unharmed.

Dr. Emily Roberts, lead researcher on the study, explains the significance of this new approach: “Targeted immunotherapy represents a major advancement in the fight against cancer. Not only does it offer the potential for more effective treatment, but it also has the potential to reduce the toxic side effects often associated with traditional therapies.”

The results of the clinical trials have been overwhelmingly positive, with a significant number of patients experiencing tumor shrinkage and improved quality of life. Patients who had previously been told they had limited treatment options are now seeing promising results with targeted immunotherapy.

The next step for researchers is to expand the clinical trials and gather more data on the long-term effectiveness of the treatment. If successful, targeted immunotherapy could revolutionize the way cancer is treated and offer hope to millions of patients around the world.

The news of this breakthrough in cancer treatment has sparked excitement and optimism within the medical community and among patients and their families. With further research and development, targeted immunotherapy could prove to be a game-changer in the fight against cancer.
Next article
RELATED ARTICLES
- Advertisment -
Google search engine

Most Popular

Recent Comments